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Abstract
This tutorial describes a method of controlled cell labeling with citrate-coated ultra small superparamagnetic iron
oxide nanoparticles. This method may provide basically all kinds of cells with sufficient magnetization to allow cell
detection by high-resolution magnetic resonance imaging (MRI) and to enable potential magnetic manipulation. In
order to efficiently exploit labeled cells, quantify the magnetic load and deliver or follow-up magnetic cells, we
herein describe the main requirements that should be applied during the labeling procedure. Moreover we
present some recommendations for cell detection and quantification by MRI and detail magnetic guiding on some
real-case studies in vitro and in vivo.
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Rationale
Magnetic labeling provides living cells with new
features, which allow cell magnetic resonance imaging
(MRI), enable distal cell manipulation applicable to tis-
sue-engineering techniques, or could be even used for
magnetically assisted cell delivery to target organs in
vivo. Among magnetic nanoparticles, superparamagnetic
iron oxide nanoparticles have an extensively documen-
ted background about particle synthesis and surface
modification. Moreover, if properly used (i.e. when well
dispersed), such particles do not alter viability, function,
proliferation or differentiation of cells. In order to
efficiently and safely label different cell types, including
stem cells, this tutorial presents a well-established
method of controlled cell labeling with citrate-coated
ultra small superparamagnetic iron oxide nanoparticles
(herein referred to as magnetic nanoparticles - MNP).
In addition, we also provide a method of detection and
quantification of single cells with high resolution MRI
and describe the basis of cell sorting and magnetic
manipulation for engineering and therapeutic purposes.
Cell labeling with magnetic nanoparticles
Background
Different strategies can be applied in order to endow cells
with sufficient magnetization to be detectable by MRI
and/or to be manipulated by an external magnetic field.
The handiest way is the co-incubation of cells with mag-
netic nanoparticles, where the particles are generally inter-
nalized through the spontaneous endocytosis pathway [1]
or phagocytosis [2]. However cellular uptake may strongly
depend on nanoparticle properties, especially on surface
functionalization [3]. While dextran-coated nanoparticles
show very poor uptake due to steric repulsions between
particles and cell membrane, the best strategy to facilitate
endocytosis of nanoparticles is to favor a specific binding
or non-specific adsorption to the cell membrane. This can
be achieved by linking biological effectors on nanoparticles
such as antibodies, transferrin or HIV-Tat peptide that
target specific receptors on plasma membrane [4]. The use
of cationic transfection agents that form highly charged
complexes with nanoparticles is also efficient to trigger
cellular uptake, but usually requires long incubation times
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(>6 hours) [5]. Moreover the aggregation state of nanopar-
ticles in the formed complexes cannot be controlled.
The importance of nanoparticle stability in cell labeling
medium
As the cells react in a different manner depending on
whether the nanoparticles remain dispersed in suspension
or become aggregated, the stability of MNPs is a key
issue to achieve an efficient and controllable magnetic
labeling. Moreover, cell toxicity might arise from MNPs
aggregates, whereas the same MNPs would have no dele-
terious effect when correctly dispersed. In addition, the
surface properties of nanoparticles can be changed upon
dynamic adsorption of the proteins and macromolecules
encountered in the biological medium. Therefore what
the cell perceives is not the original nanoparticle designed
by a chemist, but a modified heterogeneous surface
reconfigured by the biological milieu [6,7]. Both the phy-
sical state (aggregated versus isolated nanoparticles) and
the biological identity of particles (comprising the
adsorbed proteins) dictate the uptake by different cell
types and the in vivo biodistribution of nanoparticles.
Practical aspects of cell labeling
Labeling cells in vitro offers the opportunity of controlling
cell interactions with nanoparticles (Figure 1). In this
tutorial we describe a simple and straightforward method
to magnetically label virtually all cell types in a rapid,
predictive and quantitative way. The objectives and
requirements for an efficient cell labeling are summarized
in Figure 2 and the key steps in the labeling procedure are
shown on Figure 3. Our method uses citrate-coated
maghemite nanoparticles of 7-8 nm in diameter. Small
citrate ligands on the surface of the iron oxide confer
negative surface charges to the particles, which are
stabilized by electrostatic repulsions in water or serum-
free culture medium. We use serum-free culture medium
to avoid adsorption of proteins on the nanoparticles that
could affect both their stability and their affinity for the
cell membrane. Moreover the stability of citrate-coated
particles (measured through their hydrodynamic size) can
be modulated by controlling the concentration of free
citrate ions: the nanoparticles remain isolated in culture
medium supplemented with 5 mM free citrate, while they
aggregate in citrate-free medium and eventually form
Figure 1 Schematic representation of cell interactions with nanoparticles. Particles first adsorb on plasma membrane, which consequently
undergoes invagination. The MNP-loaded vesicles then pinch off the membrane and subsequently fuse with endosomes and lysosomes, which
are dispersed within the cell’s cytosol.
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chains when submitted to a magnetic field [8] (Figure 4).
Thus, to avoid MNP aggregation, cell labeling should be
performed in the serum-free medium supplemented with
citrate. While appropriate labeling conditions preserve the
homeostasis of cells, failure to provide optimal labeling
conditions might lead to particle aggregation (Figure 4)
that might have a negative impact on the cells.
After a short incubation time (typically less than one
hour, compared to several hours of cell labeling with
other types of magnetic nanoparticles), cells are rinsed
with the citrate-enriched, serum-free medium and left
for particle chase in the standard cell medium at 37°C.
Once the chase period is over, cells appearance should
be attentively examined. The main qualitative check
points are summarized in Figure 3.
Mechanistic aspects in cell labeling with MNPs
The uptake of dispersed citrate-coated MNPs consists of a
two-step process. The first step is the non-specific adsorp-
tion of particles on the plasma membrane, following a
generic Langmuir kinetics. This step can be investigated
separately if cells are maintained at 4°C, thus inhibiting
the internalization process. Remarkably the affinity of
MNPs for cell membrane does not depend on cell type
Figure 2 Schematic representation of the objectives and key requirements for efficient cell labeling.
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(1.6-4 × 107 M-1) and the binding capacity (typically 0.03
pg/µm2 or 2.4 × 104 nanoparticles/µm2), but it only
depends on cell size [9]: the larger the cell, the higher the
number of nanoparticles adsorbed on plasma membrane.
The second step involves the internalization of the plasma
membrane, which invaginates, encloses the nanoparticles
into vesicles, and delivers them into intracellular
compartments, successively to early endosomes, late
Figure 3 Labeling procedure and its qualitative checkpoints to assess labeling efficacy. The figure represents the key steps for efficient
cell labeling. The checkpoints include the evaluation of cell outlook (color, shape, presence of aggregates).
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endosomes and ultimately to lysosomes (Figure 5). At 37°
C both the particles adsorption and internalization occur
concomitantly. Moreover, the binding sites on plasma
membrane are continuously recycled, allowing continuous
internalization. As the internalization capacity and the
internalization time are conserved for different cell types
(with the exception of macrophages), this model allows
predicting quantitatively the cellular uptake and optimiz-
ing the labeling procedure in terms of incubation time and
extracellular iron concentration.
Intracellular storage of internalized particles
Intralysosomal sequestration of MNPs has the advantage
to protect the cell from the release of any free toxic iron
Figure 4 Comparison of examples of appropriate and inappropriate labeling conditions due to aggregation of anionic magnetic
nanoparticles.
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species in the cytoplasm. Moreover the lysosomes are used
by cells to metabolize MNPs and to degrade them at long
term [10,11]. Likewise the in vivo biotransformation of
MNPs occurs intracellularly within the lysosomes, and the
iron, coming from the degradation of MNPs, is locally
transferred and stored within the ferritin, the iron storage
protein [12,13].
Impact of magnetic nanoparticles on cell viability
Indeed, one of the significant aspects in cell labeling is
also the assessment of cell functions after MNP interna-
lization. Prior to the use of magnetically labeled cells for
imaging and therapeutic purposes, functional tests have
to be performed in order to check the innocuousness of
magnetic labeling on cell viability, cell proliferation, cell
phenotype and specific functionalities. Cell viability can
be assessed by different assays, which may determine
different cell characteristics, such as the integrity of cell
membrane, mitochondrial activity, apoptosis, etc. While
there are no special recommendations on which tests to
use after MNP labeling, we should compare results from
the same kind of assay if we are comparing viabilities of
different cells. Cell proliferation should be monitored
over a period of at least 5 days [9]. The preservation of
cell functions and differentiation capacities might differ
among distinct cell types, therefore should be determined
specifically. The expression of specific genes of interest
can also be quantified to assess subtle phenotypical
alterations following SPIO labeling [14,15]. An example is
given in Figure 6[8].
To date different cell types have been labeled with MNPs
(immune cells, endothelial cells, cancer cells, primary cul-
ture or established cell lines and progenitors cells, to men-
tion just a few) and detrimental effects on cell proliferation
and cell functions at short and long terms, in vitro or in
vivo, were not observed [9]. The labeling of stem cells is
Figure 5 Transmission electron micrograph of a cell loaded with magnetic nanoparticles, which are confined in endosomes or
lysosomes.
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more tricky as these cells should conserve their self-
renewal and multipotency after internalization of MNPs
[16]. Human neural precursor cells were also efficiently
labeled without impairment of their differentiation capacity
[17,18]. However in some studies using transfection agents
for cell labeling, controversial effects were observed on the
multilineage differentiation capacity of mesenchymal stem
cells. The chondrogenesis (i.e. the capacity to differentiate
in cells of cartilage) was partially inhibited in one study
[19], but not in others [14,20-22], whereas adipogenesis
and osteogenesis were not impaired. On the contrary,
while labeling cells with citrate-coated MNP, we could
modulate the amount and the physical state of nanoparti-
cles interacting with cells and could conclude that only
high dose of MNPs or an aggregated state, could have
adverse effects on cell differentiation (chondrogenesis) [8]
(Figure 6). Labeling conditions with perfectly stable MNP
is thus recommended for use in cell therapy assays.
Fate of the particles in a living cell
During the division process, the cell shares the magnetic
endosomes between its two daughter cells. The iron load
is thus reduced by a factor of two at each division. In nor-
mal conditions, there is no exocytosis of MNPs. However,
under stress conditions, some magnetically labeled cells
can release nanoparticle-loaded microvesicles in the
extracellular medium [23,24]. These cell-released vesicles
can transfer nanoparticles to other naïve cells [24],
especially macrophages [25]. This process, if confirmed in
vivo, could participate to a horizontal intercellular transfer
of nanoparticles, challenging to some extent the initial
specificity of cell labeling [26,27].
Quantification of iron load
Once the chase period is over, cells appearance should be
attentively examined. Check points are summarized in
Figure 3. After our first qualitative examinations (Figure 3),
we should proceed with the quantification of iron load.
Currently there are several methods for iron dosage in
cells, namely, the elemental analysis, the electron paramag-
netic resonance (a method which relies on magnetism and
allows the differentiation between superparamagnetic iron
from the particles and endogenous iron bound in ferritins,
the iron storing proteins) [12,28] and the colorimetric
Figure 6 Example of monitoring of cell functions after mesenchymal stem cell labeling. The figure is adapted from reference (8) and
shows cell differentiation ability. In the represented case, after labeling, cell differentiation to adipose or bone cells is not impaired at high MNPs
concentration. In contrast, high MNP load impacts cartilage formation.
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analysis, to mention just a few. Apart from these methods
that are generally applied to the cell pellet, other single
cell iron assessments can be also performed. Something of
the kind is the single cell magnetophoresis [28]. This
method also relies on magnetism and is schematized in
Figure 7.
Cell responsiveness to the magnetic forces
As lysosomes in labeled cells concentrate several millions
of MNPs, a labeled cell becomes responsive to an inho-
mogeneous magnetic field, generated, for example, by a
permanent magnet. In a non uniform magnetic field B,
defined by an unidirectional magnetic field gradient
gradB, a labeled cell experiences a magnetic force M(B)
gradB, where M(B) is the magnetic moment of the cell in
the field B (equal to the magnetic moment of one MNP
multiplied by the number of MNPs per cell). Typically a
permanent magnet generates a magnetic field gradient of
10-50 T/m over a distance of approximately 1 cm. The
corresponding force experienced by the cell (with an
average iron load of 10 pg) may vary from 1 pN to a few
nN [29]. For cells in suspension, the magnetic force is
balanced by the viscous force 6πhRV, where h is the visc-
osity of the medium, R the cell radius and V the cell
velocity. In a set-up with calibrated B and gradB (18 T/
m), it is easy to deduce iron load from the determination
of V and R for each cell by video-microscopy (Figure 7
top). From this experiment we can thus determine the
distribution of MNP uptake in a cell population (Figure 7
middle). If the cells have not been labeled in the appro-
priate way (and are consequently covered with particle
aggregates and cellular debris), magnetophoresis will not
reflect the cell velocity that is due to intracellular iron,
but will indicate the velocity that is due to internalized
and membrane-attached nanoparticles. Besides, as we can
see on Figure 7 (bottom), chains of aggregates that are
not attached to cell membranes also migrate towards the
magnet. In contrast to other global dosage of iron load in
cell pellet, single cell magnetophoresis allows to visualize
potential artifact linked to nanoparticle aggregation. The
control of nanoparticle stability is once again the critical
point to achieve a quantifiable and reproducible magnetic
labeling.
Imaging cells with magnetic resonance imaging
(MRI)
Cell tracking in vivo: the advantages of MRI
One of the new emerging applications of magnetic cell
labeling concerns magnetic resonance cell tracking. Mag-
netic resonance imaging (MRI) allows real-time whole-
body examinations with excellent soft-tissue contrast and
spatial resolution. Moreover, impactful development has
been made on high-field MR scanners, magnetic gradient
systems and radiofrequency (RF) coils [30]. One of the
new coils, such as the cryogenic probe, allows sub-
milimetric resolution and gives the means to perform cel-
lular MRI in vivo. The advantage of the cryogenic probe to
improve the signal-to-noise (SNR) ratio and concomitantly
improve the image resolution, has been demonstrated
throughout the last decade in several studies [30,31].
Iron oxide nanoparticles as cellular MRI contrast agents
In order to be distinguished from tissues, the cells have to
be labeled with a contrast agent (Figure 8). Iron oxide
nanoparticles are potent MR contrast agents that can
positively or negatively enhance the signal, depending on
particle concentrations and applied MR sequence [32].
The particles are characterized by their r1 and r2 relaxiv-
ities, which indicate the ability to increase the longitudinal
and transverse relaxation rate of proton magnetization per
mM of agent. Nevertheless, when MNPs are internalized
into endosomes or lysosomes, their contrast properties
radically change [33]: their longitudinal relaxivity is
strongly diminished due to poor accessibility of water pro-
tons among highly concentrated nanoparticles tightly
packed in endolysosomal compartments. Once within the
intracellular compartments, magnetic interactions between
MNPs also likely play a role in relaxivity variations,
increasing the r2/r1 ratio after cell internalization [34]. An
important consequence is that a magnetized cell creates a
strong localized magnetic inhomogeneity in the uniform
magnetic field of the MR scanner. Typically the field
increment is about 10-4 T at the surface of a cell (loaded
with approximately 5 pg of iron) and falls to 10-7 T at a
distance of 50 µm from the cell [33]. This cell-induced
magnetic artifact (Figure 9) can be detected with suscept-
ibility weighted imaging or T2* weighted gradient echo
sequences. Consequently, when spatial resolution is suffi-
ciently high (typically less than 100 µm), single magnetic
cells appear as focal signal voids. Single cell detection has
been proven using high field MRI [33] or the clinical 1.5 T
scanner equipped with a low noise superconducting coil
[35]. As an example, Figure 10 shows high-resolution MR
scans of agarose gels containing different numbers of indi-
vidualized magnetically labeled cells, obtained at 4.7 T
with a scanner provided with a cryogenic probe [31].
At low density, each signal void can be associated to one
single cell. Indeed, the apparent cell size, detected by MR,
is larger than the actual size of the cell and depends on
the parameters of the MR sequence (Figure 9).
Cell imaging in cell therapies
Cell tracking by MRI has become a method of choice to
evaluate cell therapies, which involve direct (local or
intravenous) administration of labeled cells (Figure 11).
At high cell densities (local injections), isolated cells can
be hardly detected, but we can observe a global signal
loss, which is less dependent on MRI parameters
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Figure 7 Single cell magnetophoresis. Schematic representation of the magnetophoresis setting (top) and iron load distribution diagrams
(middle) obtained by the magnetophoresis experiment, presented as iron load as function of time or as function of iron concentration in the
cell culture medium. When magnetophoresis is performed on cells that have not been correctly labeled, the outcome of the assay does not
reflect the correct value of the intracellular iron load (as the obtained value is higher due to extracellular aggregate pods).
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(Figure 11). In a pioneering study using cellular MRI in
vivo, MRI could be used to monitor the migration of
lymphocytes injected intravenously to tumor bearing
mice [36]. Lymphocytes were targeted to tumor cells
through immune recognition, where the MRI showed a
complex cell migration pathway. Lymphocytes first
homed to the spleen to multiply and become activated,
and only after multiplication they infiltrated the tumor
and made it regress. This study was important from a
methodological point of view, showing, for the first
Figure 8 Schematic representation of the objectives and key requirements for efficient cell imaging by MRI.
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Figure 9 The MR dephasing effect. Theoretical and real case study of the dephasing effect of protons in the vicinity of a labeled cell in vivo.
The upper panel shows the MR image of the lower hind limb of a mouse, intravenously injected with magnetically labeled macrophages, which
form a typical four-lobed clover in the susceptibility-weighted scan (in-plane resolution of 39 μm), obtained with a 4.7 T scanner provided with a
dedicated cryogenic probe. The bottom panel points out the impact of the echo time on the apparent cell size (top theoretical predictions and
bottom real case study obtained at 9.4 T). The bottom panel has been adapted from reference (46).
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time, that single cells could be detected by MRI directly
in vivo in a tumour [36]. This was extremely challen-
ging, as lymphocytes were poorly labeled after several
divisions in the spleen (and cell iron mass fell below 0.2
pg) and the imaging was made on a clinical 1.5T MR
scanner. Together with many other studies by different
groups, we can realize that MRI offers a great potential
for cell tracking, which is also progressively being inte-
grated in clinical assays. Be that as it may, despite the
fact that MRI might provide us with real-time insight in
cell distribution in vivo, we should corroborate its
results with other, even post-mortem methods of cell
detection, such as histology.
Quantification of punctual signal voids
In order to quantify detected signal voids that might corre-
late to administered magnetic cells, we should proceed
with image processing and (automatic) dot count. In MR
image processing, highly precise dot quantification
remains very complex especially in vivo where several tis-
sular structures might impact the dot count. However a
good approximation can be made with ImageJ, the open
source software from the National Institutes of Health.
The step-by-step procedure for dot quantification
obtained by ImageJ is illustrated on Figure 12.
Magnetic manipulation of cells: from cell sorting
to magnetic targeting in tissue engineering and
cell therapies
Magnetic cell sorting
Magnetic cell manipulation that applies to magnetophor-
esis can also be applied to magnetic cell sorting (Figure 13),
where we can separate cells in respect to their magnetic
load [38]. This may be particularly advantageous when we
want a precise and homogenous iron load within a cell
fraction and/or want to eliminate poorly loaded cells that
would, for example, be less detectable by MRI or less
responsible to magnetic targeting. Moreover, magnetic cell
sorting could be used to separate magnetic cells from
complex mixtures or to sort cells with respect to their
endocytosis capacity.
Impact of the magnetic force
The effect of magnetic forces on cells will be also tightly
related to the fact if the cell is suspended in a liquid or
if it adheres on a substrate. While suspended cells more
or less freely move when submitted to remote magnetic
forces, when we try to magnetically manipulate adhering
cells and the magnetic force is lower than the adhesion
constraint, the cell cannot move and the magnetic force
acts on MNP loaded intracellular endo-lysosomes. Such
Figure 10 Cell detection as function of labeling conditions. A case study of agarose phantoms spiked with the same amount of cells,
labeled with ascending concentrations of iron. The images were obtained with a T2* weighted gradient echo sequence, with a 4.7 T scanner
provided with a dedicated cryogenic probe. The figure is adapted from reference (31).
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intracellular constraints can be used to deform the cell
in a controlled direction and could be used, for example,
to control the formation of a vascular network with
magnetically labeled endothelial progenitor cells [39].
Magnetic manipulation might allow enhanced cell seed-
ing and engraftment in different scaffolds for tissue
engineering [40] and may enable new perspectives for in
vitro construction of organized multicellular assemblies
and tissue substitutes [41].
Magnetic vectorization: the response to the need for
localized cell delivery
For what concerns magnetic cell manipulation in vivo, a
new field of therapeutic delivery- the magnetic vectorization
Figure 11 High-resolution of murine hind limbs injected with labeled cells or phosphate saline buffer (PBS) only. Top: mice intra-
muscularly (left) or intravenously (right) injected with labeled macrophages. Bottom: mice intra-muscularly (left) or intravenously (right) injected
with PBS. The images were obtained with a 4.7 T scanner provided with a dedicated cryogenic probe.
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or magnetic targeting of cells is emerging (see Figure 14
for the main objectives and requirements for magnetic
cell targeting). This might be particularly interesting for
cell guiding in stem cell transplantation for regeneration
of injured tissues. Nevertheless while a substantial thera-
peutic effect was expected from stem cell treatment in
acute or chronic cardiac ischemia, the treatment showed
moderate therapeutic benefit in preclinical trials. Stem
cell transplantation failed to improve the myocardial
function, mainly because the majority of injected cells
escape from the injured site, due to the local blood flow,
which washes away the cells, and cardiac contractions,
which squeeze the cells out, leading to poor cell engraft-
ment (generally only less than 10% of the originally
injected cells remain in the injured area). In order to
enhance cell retention, some recent studies have
proposed magnetic targeting in different cell therapies.
However, to date, it is still uncertain if magnetic forces
applied to cells would overcome the forces induced by
the bloodstream and/or if the cells would still persist in
the target place, once the magnet would be withdrawn.
Magnetic vectorization was recently evaluated for car-
diac cell transplantation, where magnetically labeled
endothelial progenitor cells were injected in the infarcted
myocardium while a magnet was externally applied to rats
in the heart zone. Magnetically assisted cell delivery
resulted in an increased concentration of cells and the
short-term effect on cell retention was monitored in vivo
by MRI and quantified by RT-PCR [42]. In a study evalu-
ating the long-term engraftment, the functional benefits of
magnetically assisted cell retention were also confirmed
[43], improving cardiac ventricular function.
Practical aspects for magnetic vectorization
A first step towards an effective magnetic targeting is to
prepare viable magnetic cells, which will be responsive
Figure 12 Representation of a simplified procedure for relative dot quantification in vitro and in vivo. Image processing was performed
with the open source ImageJ software.
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to the given magnetic force. Before any in vivo application,
we should therefore assess in vitro the best parameters for
the magnetic manipulation of cells (Figure 15). Indeed the
conditions in gels are only a poor approximation of what
will happen after cell administration to living beings. Any-
way, this pre-assessment does, however, allow us to see at
least if we reached the minimal magnetization that might
enable distal cell guiding. Before we translate cell vectori-
zation to animals, we can also assess how magnet retains
cells during the stirring of agarose phantoms. Other
approaches might be more complex and can theoretically
and experimentally evaluate the effect of cell aggregation
after magnetic cell targeting in models simulating vessel
bifurcation [44].
Once we endowed cells with sufficient magnetization
for cell vectorization, we can proceed to magnetic
targeting in vivo (Figure 16). When we disperse labeled
cells in the injection medium (which is generally the
PBS), magnetic cells tend to be more prone to aggrega-
tion than non-labeled cells. If cell aggregates are injected
intravenously, they will block the vessels (especially the
small pulmonary ones) and the animals will die. In
order to thoroughly disperse the cells, it is therefore
necessary to disperse cells with a pipette cone or even
pump the suspension in and out of the syringe for
several times. This procedure might eventually lead to
cell lysis, consequently, after such methods of disper-
sion, we should assess cell viability. If the viability is
compromised, we have to disperse and administer cells
by a syringe with a smaller gauge number (larger needle
diameter). Nevertheless, even if administered cells are
individualized, they might, under certain conditions,
form perivascular aggregates within the body after
magnetic guiding [45].
Figure 13 Magnetic cell sorting set-up. A) The photograph of the microfluidic chip showing the cell and buffer inlet, the separation chamber
and five exit channels. Within the chamber, each cell population will move towards a specific exit. B) The migration of differently loaded
macrophages towards their respective exits is driven by the value of the magnetic field gradient along the cell’s trajectory and by the cell’s
magnetic load. C) The iron load of each cell fraction was quantified by the single-cell magnetophoresis. The figure is adapted from reference
(38).
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As we mentioned in the previous section, MRI allows in
vivo follow up of magnetic cells and could be therefore
used to confirm successful magnetic cell targeting. Never-
theless, in addition to this method, we should confirm that
visualized spots correspond to injected cells. This might be
done by immunohistological methods or flow cytometer
analysis post mortem. Sometimes, especially if the cells are
administered in low concentrations and systemically, the
cells are difficult to find both by histology and flow
cytometry. If we cannot localize the cells with these or
other methods of cell detection, we should at least have a
proof of an important therapeutic effect that could serve as
a surrogate marker of cell delivery and local action.
Summary and conclusion
Iron oxide nanoparticles can be used for magnetic label-
ing of different types of cells. The labeling of living cells
allows a variety of biomedical applications ranging from
cell manipulation to diagnostics and regenerative
medicine. This tutorial provides the basic requirements
for efficient cell labeling with anionic (citrate coated)
iron oxide nanoparticles and includes sections on trou-
bleshooting to prevent the occurrence of potential cell
damage during the labeling procedure. In addition, as
single cells can be monitored by high resolution MRI,
we provide some appreciation of cellular MRI and
present an abridged method for the quantification of
Figure 14 Schematic representation of the objectives and key requirements for magnetic cell vectorization.
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Figure 15 Magnetic vectorization of cells in agarose gels with different magnets. The figure shows the MR scans of two agarose gels,
where magnets of different size and strength were put on the tube’s surface (left panel). Blue squares and arrows indicate the zone where cells
preferentially cumulate due to the applied magnet.
Figure 16 Magnetic vectorization of labeled bone marrow derived cells in a healthy mouse. MR scans showing hind limb scans of an
animal. The blue square indicates the zone where cells preferentially cumulate due to the applied magnet.
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punctual signal voids that are generated in vitro and in
vivo by labeled cells. Finally, we also assess the potential
of cell manipulation that can be exploited both in vitro
for tissue engineering and in vivo in cell therapies.
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